Yes, but this is vastly different to what PYC is doing.
Yuyu Pharma is simply developing an ophthalmic solution for dry eye disease which is based on a synthetic peptide with anti-inflammatory peptides.
https://www.bloomberg.com/press-rel...ead-studies-for-its-dry-eye-treatment-peptide
Valuing PYC, page-81
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PYC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $793.2M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 17.5¢ | 16.5¢ | $182.4K | 1.076M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 338966 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 244886 | 5 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| PYC (ASX) Chart |